-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2006_MaskedStats_IP.PDF
January 01, 2006 - Means of Continuous Data Elements
Variable / Label N N Miss Minimum Maximum Mean Std Dev
DISCWT : Weight … :13 Friday, June 19, 2009 31
Univariates of Selected Continuous Data Elements
Variable: DISCWT (Weight … :13 Friday, June 19, 2009 31
Univariates of Selected Continuous Data Elements
Variable: DISCWT (Weight
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/diabetes-behavior-programs_disposition-comments.pdf
September 28, 2015 - TEP 1 General The analyses included the change (primarily) in A1c
and body weight at 12/24 months. … typically
change in A1c, while the main outcome in a lifestyle
intervention is typically change in weight
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_1997_SummaryStats_CORE.PDF
January 01, 1997 - please refer to the section on Description of Data Elements.
For more information about the coding of HCUP data elements,
HCUP Summary Statistics Report: KID 1997 - CORE File 1
Means of Continuous Data Elements 14:38 Monday, May 8, 2006
please refer to the section on Description of Data Elements.
For more informatio…
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary9/alcohol-misuse-screening-and-behavioral-counseling-interventions-in-primary-care-2013
September 25, 2012 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Evidence Summary
Alcohol Misuse: Screening and Behavioral Counseling Interventions in Primary Care
September 25, 2012
Recommendations made by the USPSTF are independen…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/-KMSTWRT9xbm7spaqDq_GE
February 12, 2019 - symptoms,39 mental health treatment,40 breastfeeding,38 child
development,49 child attachment,49 birth weight … and preterm
birth.42 Of these, 1 trial (n = 184) showed statistically significant ben-
efits on birth weight
-
effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
January 01, 2012 - The delivery system (which is also being evaluated for delivering drugs for hepatitis and
weight loss … The company also
reported that the drug led to reduced body weight after 24 and 48 weeks of treatment … Subjects taking Lira lost more weight (-3.58 kg, SE 0.18)
than those taking EQW (-2.68 kg, SE 0.18; … Similar reductions in mean body
weight from baseline to week
12
24 were observed in both groups … Several experts noted that subcutaneous exenatide
use would also result in effective weight loss.
-
effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
January 01, 2012 - The delivery system (which is also being evaluated for delivering drugs for hepatitis and
weight loss … The company also
reported that the drug led to reduced body weight after 24 and 48 weeks of treatment … Subjects taking Lira lost more weight (-3.58 kg, SE 0.18)
than those taking EQW (-2.68 kg, SE 0.18; … Similar reductions in mean body
weight from baseline to week
12
24 were observed in both groups … Several experts noted that subcutaneous exenatide
use would also result in effective weight loss.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
January 01, 2012 - The delivery system (which is also being evaluated for delivering drugs for hepatitis and
weight loss … The company also
reported that the drug led to reduced body weight after 24 and 48 weeks of treatment … Subjects taking Lira lost more weight (-3.58 kg, SE 0.18)
than those taking EQW (-2.68 kg, SE 0.18; … Similar reductions in mean body
weight from baseline to week
12
24 were observed in both groups … Several experts noted that subcutaneous exenatide
use would also result in effective weight loss.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary25/screening-for-abnormal-blood-glucose-and-type-2-diabetes
April 13, 2015 - Individual lifestyle counseling session aimed at decreasing body weight and increasing physical activity … Intensive lifestyle intervention, including diet and exercise to achieve modest weight reduction (n=1,048 … Individual session and goal to decrease weight by 5% with follow up at 1, 3, 6, 12, 18, 24, 30, and 36 … months (n=330)
B. 1 session of advice to reduce weight by 5% (n=311)
Patients with IGT and BMI … Lifestyle counseling, including weight loss 7% over 3 months, diet information, walking 30 minutes per
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary34/lipid-disorders-in-children-screening-2007
July 15, 2007 - children include dietary supplements (fiber, sterol or stanol margarines, omega-3 fatty acids), exercise, weight … studies reported normal height growth, 170 , 190 , 234-236 , 239 , 240 , 242 , 243 , 245-247 although weight … 37%
650
20
specificity calculated
1,005, ages 2-13, 8 office practices
Overweight (weight … 90th percentile
57%
NR
N/A
42
1,005, ages 2-13, 8 office practices
Overweight (weight … Abdominal pain (3), chest pain (1), flatulence (1), myalgia (2), headache (4), sleep disorder (1), weight
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary25/screening-for-abnormal-blood-glucose-and-type-2-diabetes-october-2015
April 13, 2015 - Individual lifestyle counseling session aimed at decreasing body weight and increasing physical activity … Intensive lifestyle intervention, including diet and exercise to achieve modest weight reduction (n=1,048 … Individual session and goal to decrease weight by 5% with follow up at 1, 3, 6, 12, 18, 24, 30, and 36 … months (n=330)
B. 1 session of advice to reduce weight by 5% (n=311)
Patients with IGT and BMI … Lifestyle counseling, including weight loss 7% over 3 months, diet information, walking 30 minutes per
-
cds.ahrq.gov/taxonomy/term/69806
August 23, 2024 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/atrial-fibrillation-screening-with-electrocardiography
August 07, 2018 - (KQ4)
Weights are from random-effects meta-analysis; size of data markers indicates the weight … (KQ5)
Weights are from random-effects meta-analysis; size of data markers indicates the weight
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/chipra-factors-influencing-state-reporting.pdf
July 01, 2016 - hyperactivity Administrative m • • •
disorder (ADHD) medication
Care of acute and chronic conditions
Weight
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/chipra-factors-influencing-state-reporting.pdf
July 01, 2016 - hyperactivity Administrative m • • •
disorder (ADHD) medication
Care of acute and chronic conditions
Weight
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/chipra-factors-influencing-state-reporting.pdf
July 01, 2016 - hyperactivity Administrative m • • •
disorder (ADHD) medication
Care of acute and chronic conditions
Weight
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/chipra-factors-influencing-state-reporting.pdf
July 01, 2016 - hyperactivity Administrative m • • •
disorder (ADHD) medication
Care of acute and chronic conditions
Weight
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/chipra-factors-influencing-state-reporting.pdf
July 01, 2016 - hyperactivity Administrative m • • •
disorder (ADHD) medication
Care of acute and chronic conditions
Weight
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/chipra-factors-influencing-state-reporting.pdf
July 01, 2016 - hyperactivity Administrative m • • •
disorder (ADHD) medication
Care of acute and chronic conditions
Weight
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/chipra-factors-influencing-state-reporting.pdf
July 01, 2016 - hyperactivity Administrative m • • •
disorder (ADHD) medication
Care of acute and chronic conditions
Weight